Literature DB >> 1138333

The formation of bile acids in patients with portal liver cirrhosis.

K Einarsson, K HEllström, T Schersten.   

Abstract

Bile acid kinetics were characterized in 8 patients with portal liver cirrhosis with the aid of 24-14C-cholic acid and randomly 3H-labelled chenodeozycholic acid. Although not significant on a statistical basis, pool size, synthesis, and fractional turnover of cholic acid in the cirrhotic patients tended to be smaller than in normolipidaemic controls without evidence of liver disease. The most significant findings in the present patients were the subnormal cholic acid: chenodeoxycholic acid ratio of both bile acid pool size and synthesis and the low concentrations of deozycholic acid in duodenal bile specimens. Possible explanations for these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138333

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  The metabolism of steroids in the fatty liver induced by orotic acid feeding.

Authors:  M Carrella; I Björkhem; J A Gustafsson; K Einarsson; K Hellström
Journal:  Biochem J       Date:  1976-07-15       Impact factor: 3.857

2.  [Pathogenic significance of bile acids (author's transl)].

Authors:  W Gerok; S Matern
Journal:  Klin Wochenschr       Date:  1981-06-15

3.  Effect of cholestyramine on bile acid kinetics in patients with portal cirrhosis of the liver. Evidence of a selective defect in the formation of cholic acid.

Authors:  B Angelin; K Einarsson; K Hellstrom
Journal:  Am J Dig Dis       Date:  1978-12

4.  Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119.

Authors:  M Nissenbaum; A Chedid; C Mendenhall; P Gartside
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

5.  Biliary lipid metabolism in children with chronic intrahepatic cholestasis.

Authors:  M Becker; K von Bergmann; H W Rotthauwe; O Leiss
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.